Patent details

EP2224927 Title: PTERIN ANALOG FOR TREATING BH4 RESPONSIVE CONDITION

Basic Information

Publication number:
EP2224927
PCT Application Number:
PCT/US/2008/069319
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087814356
PCT Publication Number:
WO/2009/088530
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PTERIN ANALOG FOR TREATING BH4 RESPONSIVE CONDITION
French Title of Invention:
ANALOGUE DE LA PTÉRINE POUR LE TRAITEMENT D'UN ÉTAT RÉAGISSANT À LA BH4
German Title of Invention:
PTERIN-ANALOGON ZUR BEHANDLUNG EINES AUF BH4 ANSPRECHENDEN ZUSTANDS
SPC Number:

Dates

Filing date:
07/07/2008
Grant date:
20/08/2014
EP Publication Date:
20/08/2014
PCT Publication Date:
16/07/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/09/2010
EP B1 Publication Date:
20/08/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/07/2015
Expiration date:
07/07/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/07/2008
 
 

Name:
BioMarin Pharmaceutical Inc.
Address:
105 Digital Drive, Novato, CA 94949, United States (US)

Inventor

Name:
KAKKIS Emil, D.
Address:
United States (US)

Priority

1

Priority Number:
18735 P
Priority Date:
03/01/2008
Priority Country:
United States (US)

2

Priority Number:
19753 P
Priority Date:
08/01/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 475/04;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages